Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
ILMN - Illumina, Inc.
Market Cap 29.97B P/E - EPS this Y 3.50% Ern Qtrly Grth -
Income -1.16B Forward P/E 60.37 EPS next Y 174.20% 50D Avg Chg -3.00%
Sales 4.5B PEG 6.03 EPS past 5Y -38.86% 200D Avg Chg -9.00%
Dividend N/A Price/Book 4.47 EPS next 5Y 22.90% 52W High Chg -24.00%
Recommedations 2.50 Quick Ratio 1.15 Shares Outstanding 159.26M 52W Low Chg 6.00%
Insider Own 0.25% ROA -0.53% Shares Float 158.41M Beta 1.19
Inst Own 96.77% ROE -18.81% Shares Shorted/Prior 5.27M/5.21M Price 189.56
Gross Margin 65.30% Profit Margin -25.78% Avg. Volume 1,549,306 Target Price 152.15
Oper. Margin -2.94% Earnings Date May 2 Volume 1,029,324 Change 0.14%
Healthcare | Diagnostics & Research | United States
About Illumina, Inc.

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.

Illumina, Inc. News
04/25/24 Illumina (ILMN) Expected to Beat Earnings Estimates: Should You Buy?
04/25/24 These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
04/25/24 20 Countries with the Highest Rates of Stomach Cancer in the World
04/23/24 Illumina (NASDAQ:ILMN) investors are sitting on a loss of 71% if they invested three years ago
04/21/24 This CEO has battled billionaire activist Carl Icahn twice — here's his advice to Disney CEO Bob Iger
04/19/24 20 Countries with the Highest Cancer Survival Rates in the World
04/19/24 Can Illumina (ILMN) Keep the Earnings Surprise Streak Alive?
04/18/24 Engineering a Cool Career in Biotech - and Volunteering Along the Way
04/18/24 QQQ Has Some Inexpensive Growth Stocks
04/17/24 Evidence Supports Sequencing As First-Line Rare Disease Diagnostic
04/15/24 European Commission approves Illumina’s proposed Grail split
04/12/24 Illumina's planned divestment of GRAIL approved by the European Commission
04/12/24 UPDATE 2-EU approves Illumina's plan to divest cancer test maker Grail
04/12/24 EU approves Illumina's plan to divest cancer test maker Grail
04/10/24 Search for Cancer Blood Test Continues Despite Illumina-Grail Deal’s Failure
04/09/24 Illumina CFO steps down amid executive shakeup
04/09/24 UPDATE 2-Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed
04/09/24 Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed
04/09/24 Illumina appoints Ankur Dhingra Chief Financial Officer, Jakob Wedel Chief Strategy and Corporate Development Officer
04/05/24 Nasdaq’s Nosebleed Section: 3 Expensive Stocks to Sell Before It’s Too Late
ILMN Chatroom

User Image SeeTheFuture Posted - 5 hours ago

$TXG I've pulled the trigger here and added this to my genetics basket so they can join $CRSP $NTLA $ILMN This sector has a bright future.

User Image tarzzanman Posted - 6 hours ago

$ILMN Added!

User Image v92 Posted - 8 hours ago

$PACB Buyout rumors should start soon, taking it to $5 before $ILMN acquires for $10.

User Image stannoxane Posted - 1 day ago

$ILMN $130 by Friday !!

User Image PG_Trader Posted - 1 day ago

$ILMN Quiet here, I like it.

User Image flbulltrader Posted - 2 days ago

$ILMN back in again!

User Image stannoxane Posted - 4 days ago

$ILMN 126+ on Monday

User Image stannoxane Posted - 1 week ago

$ILMN fk madarchod

User Image STOCKPICKERTRADER Posted - 1 week ago

$PFE loads of other over cooked biotech/pharma companies out there if you look around, but feeling a bit overdone and seeing some potential bottoming in number of them. Few more below to add to prior lists - still like Pfizer as one of the top better/bigger plays. $IONS $NTLA $ILMN

User Image Stock_Titan Posted - 1 week ago

$ILMN Engineering a Cool Career in Biotech - and Volunteering Along the Way https://www.stocktitan.net/news/ILMN/engineering-a-cool-career-in-biotech-and-volunteering-along-the-dikcpa4jhkz9.html

User Image sogenerous Posted - 1 week ago

As all the other genomics companies go bankrupt like $NVTA $PSNL $PACB - hopefully $ILMN will be last man standing and a resurgent eventually

User Image _StockDoc_ Posted - 1 week ago

$ILMN exactly where this is headed

User Image RL29 Posted - 1 week ago

$ILMN. Chances are high if fibo 50%@118.80 retracement thereabouts cannot hold. It fell intraday to 116.8 showing weak daily candle closing - bad news. Support is now or never! Israel attempting to drag US into an unwilling war with Iran is bad news. Ukraine is losing badly & US attempting to throw another US$61bil unto it will cause inflation. Reducing rate now is difficult as forex will dump US dollar causing more inflation. 1c

User Image LadyBABA Posted - 1 week ago

$ILMN gunna put in a double bottom

User Image v92 Posted - 1 week ago

$PACB $ILMN licking their chops.

User Image Stock_Titan Posted - 1 week ago

$ILMN Evidence Supports Sequencing As First-Line Rare Disease Diagnostic https://www.stocktitan.net/news/ILMN/evidence-supports-sequencing-as-first-line-rare-disease-xbuvcri9ithu.html

User Image SilverEagle Posted - 1 week ago

$ILMN straight through the volume shelf gap right to 117 support.

User Image mcoliver Posted - 1 week ago

$PACB 350 million market cap. Good thing the government blocked a 1.2 billion acquisition by $ILMN back in 2020 /s. Look at all the value they protected in both shareholder returns and jobs.

User Image RL29 Posted - 1 week ago

$ILMN. Summary reports on Iranian retaliatory move against Israeli. ISW Arab news analysis on the drones & missiles delivered to Israel targeting military installations, intelligence & espionage bases: – The Nevatim Airbase in southern occupied Palestine – The Ramon Airbase in southern occupied Palestine – An intelligence and espionage base of the Israeli regime in Jabal al-Sheikh (Mount Hermon) in the northern occupied Golan Heights. https://english.iswnews.com/34551/operation-true-promise-which-of-the-israeli-bases-targeted-in-the-retaliatory-missile-and-drone-attack-by-iran/ This will whimper Israeli & US from an open war with Iran.

User Image EderT Posted - 1 week ago

$ILMN this price is a bargain for patient investors. Pacific bio the only contender for their monopoly just about to go bankrupt.

User Image sogenerous Posted - 1 week ago

$PACB maybe $ILMN can by their assets in a bankruptcy

User Image _StockDoc_ Posted - 1 week ago

$ILMN losing 15% a week good?

User Image stannoxane Posted - 1 week ago

$ILMN interest rates

User Image _StockDoc_ Posted - 1 week ago

$ILMN 90 dollar stock at 5% 10year

User Image tarzzanman Posted - 1 week ago

$ILMN wtf is wrong with this stock again

User Image stannoxane Posted - 1 week ago

$ILMN 138 tomorrow

User Image 11thestate Posted - 2 weeks ago

🎯 Delaware Supreme Court upholds decision in Carl Icahn's litigation against $ILMN board.

User Image Stock_Titan Posted - 2 weeks ago

$ILMN Illumina's planned divestment of GRAIL approved by the European Commission https://www.stocktitan.net/news/ILMN/illumina-s-planned-divestment-of-grail-approved-by-the-european-xubjevwhf78y.html

User Image SM07 Posted - 2 weeks ago

$ILMN Now that Grail is gone, the company should for once focus on a sales rather than another aborted acquisition.

User Image Ro_Patel Posted - 2 weeks ago

Goldman: Historically been difficult to deliver consecutive rapid sales growth $MDB $DLR $ILMN $TSLA $FICO

Analyst Ratings
Barclays Underweight Apr 10, 24
Stephens & Co. Overweight Apr 10, 24
RBC Capital Outperform Apr 9, 24
OTR Global Mixed Mar 20, 24
Stephens & Co. Overweight Feb 14, 24
RBC Capital Outperform Feb 9, 24
Barclays Underweight Jan 25, 24
TD Cowen Market Perform Jan 4, 24
RBC Capital Outperform Dec 19, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
TOUSI SUSAN H SVP, Chief Commercia.. SVP, Chief Commercial Officer Aug 22 Sell 167.04 500 83,520 45,524 08/24/23
TOUSI SUSAN H SVP, Chief Commercia.. SVP, Chief Commercial Officer Jul 24 Sell 190.08 500 95,040 46,022 07/26/23
TOUSI SUSAN H SVP, Chief Commercia.. SVP, Chief Commercial Officer Jun 22 Sell 200.00 500 100,000 46,522 06/26/23
Hoyt Aimee L SVP, Chief People Of.. SVP, Chief People Officer Mar 01 Sell 199.06 3,917 779,718 2,881 03/03/23
Aravanis Alexander SVP, Chief Technolog.. SVP, Chief Technology Officer Feb 21 Sell 201.79 5,398 1,089,262 2,922 02/23/23
Aravanis Alexander SVP, Chief Technolog.. SVP, Chief Technology Officer Feb 21 Option 0 9,292 12,214 02/23/23
TOUSI SUSAN H SVP, Chief Commercia.. SVP, Chief Commercial Officer Feb 06 Sell 211.57 500 105,785 38,276 02/08/23
TOUSI SUSAN H SVP, Chief Commercia.. SVP, Chief Commercial Officer Jan 06 Sell 204.58 500 102,290 38,662 01/10/23
Aravanis Alexander SVP, Chief Technolog.. SVP, Chief Technology Officer Nov 05 Sell 218 361 78,698 2,857 11/08/22
Aravanis Alexander SVP, Chief Technolog.. SVP, Chief Technology Officer Jul 05 Sell 200 539 107,800 3,346 07/07/22
TOUSI SUSAN H SVP, Chief Commercia.. SVP, Chief Commercial Officer Jun 10 Sell 214.85 250 53,712 41,833 06/14/22
Hoyt Aimee L SVP, Chief People Of.. SVP, Chief People Officer Apr 12 Sell 347.54 2,474 859,814 5,342 04/14/22
Dadswell Charles SVP & General Counse.. SVP & General Counsel Mar 28 Sell 342.83 368 126,161 7,795 03/30/22
TOUSI SUSAN H SVP, Chief Commercia.. SVP, Chief Commercial Officer Jan 12 Sell 425.00 800 340,000 39,274 01/13/22
Aravanis Alexander SVP, Chief Technolog.. SVP, Chief Technology Officer Oct 19 Sell 412.46 2,926 1,206,858 10,531 10/21/21
Aravanis Alexander SVP, Chief Technolog.. SVP, Chief Technology Officer Oct 12 Sell 409.37 2,926 1,197,817 13,457 10/14/21
Hoyt Aimee L SVP, Chief People Of.. SVP, Chief People Officer Sep 08 Sell 443.24 3,372 1,494,605 3,757 09/08/21
Febbo Phillip G. SVP Chief Medical Of.. SVP Chief Medical Officer Jun 14 Sell 447.61 1,000 447,610 4,461 06/14/21
FLATLEY JAY T Director Director Feb 18 Sell 498.48 4,500 2,243,160 3,500 02/18/21
Hoyt Aimee L SVP, Chief People Of.. SVP, Chief People Officer Jan 12 Sell 379.65 271 102,885 2,359 01/12/21
deSouza Francis A President and CEO President and CEO Jan 06 Sell 370.51 3,000 1,111,530 55,540 01/06/21
Ronaghi Mostafa SVP, Entrepreneurial.. SVP, Entrepreneurial Devlopmt Dec 14 Sell 338.83 5,000 1,694,150 80,162 12/14/20
FLATLEY JAY T Director Director Dec 02 Sell 323.94 4,000 1,295,760 192,933 12/02/20
FLATLEY JAY T Director Director Nov 19 Sell 297.37 3,000 892,110 196,933 11/19/20
MCGINNIS KAREN K VP, Chief Accounting.. VP, Chief Accounting Officer Nov 09 Sell 310.1 312 96,751 1,872 11/09/20
Hoyt Aimee L SVP, Chief People Of.. SVP, Chief People Officer Nov 09 Sell 310.1 215 66,672 3,098 11/09/20
Febbo Phillip G. SVP Chief Medical Of.. SVP Chief Medical Officer Nov 09 Sell 310.1 155 48,066 2,143 11/09/20
FLATLEY JAY T Director Director Nov 04 Sell 297.51 3,000 892,530 199,933 11/04/20
deSouza Francis A President and CEO President and CEO Nov 04 Sell 300.05 3,000 900,150 65,840 11/04/20
FLATLEY JAY T Director Director Oct 22 Sell 322.48 4,000 1,289,920 202,933 10/22/20